A recent study conducted at the University of Oxford’s Radcliffe Department of Medicine has revealed alarming statistics about the impact of type 2 diabetes on individuals diagnosed before the age of 40. The study, published in The Lancet Diabetes & Endocrinology, found that young adults with type 2 diabetes have nearly four times the risk of death compared to the general population in the UK.
The research, which analyzed data from the UK Prospective Diabetes Study spanning over 30 years and involving 4,550 participants aged 25 to 65, highlighted the increased risk of mortality and complications associated with a younger age of diabetes diagnosis. Individuals diagnosed at a younger age were found to have a higher rate of diabetes-related complications, particularly microvascular diseases such as eye damage and kidney failure. Poorer blood sugar control was also observed in this group.
Professor Amanda Adler, co-author of the study, emphasized the aggressive nature of younger-onset type 2 diabetes, which may lead to faster deterioration in β-cell function and a greater risk of cardiovascular and kidney diseases. Lead author Dr. Beryl Lin stressed the importance of providing high-quality care to young adults with type 2 diabetes to prevent complications and premature death.
The study underscores the need for tailored treatments and clinical trials focused on young people with type 2 diabetes to improve outcomes and reduce the risk of complications. Researchers are calling for further investigation into why young adults with type 2 diabetes face greater risks of complications and how to better support this vulnerable group throughout their lives.
The findings of this study serve as a wake-up call for healthcare providers and policymakers to prioritize the care and management of young adults with type 2 diabetes. With early intervention and targeted interventions, it is possible to mitigate the risks associated with diabetes and improve the quality of life for those living with this chronic condition.
For more information on the study, you can refer to the publication in The Lancet Diabetes & Endocrinology titled “Younger-onset compared with later-onset type 2 diabetes: an analysis of the UK Prospective Diabetes Study (UKPDS) with up to 30 years of follow-up (UKPDS 92).”doi: 10.1016/S2213-8587(24)00242-0
This research was provided by the University of Oxford.
